Literature DB >> 7516444

Roles of histological findings and serum AFP levels in the prognosis of AFP-producing gastric cancers.

K Uefuji1, T Ichikura, S Tamakuma.   

Abstract

We investigated the roles of histological findings and serum AFP levels in the prognosis of gastric cancers which produce AFP. We considered the typical features of such gastric cancers to be the medullary growth of undifferentiated cancer cells with clear, or slightly eosinophilic, abundant cytoplasm and pleomorphic large round nuclei, forming either papillary clear carcinomas or hepatoid carcinomas. Seventeen patients with AFP-producing gastric cancers were observed in the period, 1979-1991. They were divided into two groups: those with (n 5) and those without (n 12) the typical histological features mentioned above. Their clinicopathological findings and prognoses were compared. Both groups showed a male dominance, gross Borrmann's type 2 or 3 appearances, diagnoses made at an advanced stage and metastatic involvements of the liver. The patients with the typical histological features showed a significantly higher AFP serum level and a significantly shorter survival. The patients who lacked the typical findings, and with serum AFP levels > or = 100 ng/ml, had poorer prognoses, while those lacking the typical histological features, and serum AFP levels < 100 ng/ml had better prognoses. The combination of histological findings and serum AFP level appeared to be useful in predicting the prognosis of AFP-producing gastric cancers. Intensive adjuvant therapy, e.g., chemotherapy administered via hepatic arterial infusion, may be indicated for patients at a high risk of recurrence following curative surgery.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7516444

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  6 in total

1.  Double cancer of the stomach, one AFP-producing tumor.

Authors:  T Hyodo; R Kawamoto
Journal:  J Gastroenterol       Date:  1996-12       Impact factor: 7.527

2.  Clinical and prognostic characteristics of papillary clear carcinoma of stomach.

Authors:  K Uefuji; T Ichikura; S Tamakuma
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

3.  IMMUNOBIOLOGICAL MONITORING OF VARIOUS GASTROINTESTINAL AND PRIMARY HEPATIC MALIGNANCIES.

Authors:  G S Chopra; K B Mishra; L S Vohra; M P Jaiprakash; J R Bhardwaj
Journal:  Med J Armed Forces India       Date:  2017-06-26

4.  Prolonged Survival in a Case of Chemotherapy-Sensitive Gastric Cancer That Produced Alpha-Fetoprotein and Protein Induced by Vitamin K Antagonist-II.

Authors:  Naotaka Ogasawara; Emiko Takahashi; Tomoko Matsumoto; Manami Amaike; Mako Nohara; Kazuhiro Nagao; Masahide Ebi; Yasushi Funaki; Makoto Sasaki; Kunio Kasugai
Journal:  Case Rep Gastroenterol       Date:  2015-04-24

5.  Clinicopathological features and prognosis of AFP-producing colorectal cancer: a single-center analysis of 20 cases.

Authors:  Fei Ren; Weiwei Weng; Qiongyan Zhang; Cong Tan; Midie Xu; Meng Zhang; Lei Wang; Weiqi Sheng; Shujuan Ni; Dan Huang
Journal:  Cancer Manag Res       Date:  2019-05-16       Impact factor: 3.989

6.  Whole-exome sequencing of alpha-fetoprotein producing gastric carcinoma reveals genomic profile and therapeutic targets.

Authors:  Jun Lu; Yongfeng Ding; Yanyan Chen; Junjie Jiang; Yiran Chen; Yingying Huang; Mengjie Wu; Chengzhi Li; Mei Kong; Wenyi Zhao; Haohao Wang; Jing Zhang; Zhongqi Li; Yimin Lu; Xiongfei Yu; Ketao Jin; Donghui Zhou; Tianhua Zhou; Fei Teng; Haibin Zhang; Zhan Zhou; Haiyong Wang; Lisong Teng
Journal:  Nat Commun       Date:  2021-06-24       Impact factor: 14.919

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.